​What is Orforglipron, the pill alternative to Ozempic

Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 diabetes and obesity. Unlike injectable GLP-1s like Ozempic, orforglipron offers a convenient, needle-free alternative with no food or water restrictions. Clinical trials demonstrated significant A1C reduction, and the drug's safety profile is consistent with other GLP-1 medications.